A new G-protein was detected in human platelets which was ADP-ribosylated in a pertussis-toxin-dependent manner, was located in the supernatant of saponized platelets and was of a slightly lower molecular mass (40 kDa) than platelet membrane Gia. This soluble ADP-ribosylated protein was immunoprecipitated by an antiserum to G1a, but not by one to Goa. Prior thrombin stimulation of platelets led to an inhibition of the ADP-ribosylation of this protein. This inhibition was evident even under conditions which abolished the thrombin-stimulated inhibition of membrane Gia ADPribosylation. These results indicate that the platelet thrombin receptor is coupled to two structurally and functionally distinct Gia proteins: a major Gia protein present in platelet membranes, and a minor Gia protein detectable in the platelet soluble fraction.
INTRODUCTION
Guanine-nucleotide-binding proteins (G-proteins) are a growing family of regulatory proteins which couple membrane receptors to effector proteins which generate an intracellular response [1, 2] . Activation of a heterotrimeric G-protein by an agonist-occupied receptor results in exchange of bound GDP for GTP in the a-subunit and dissociation of the a-subunit from the ,f,y complex. At least nine different Gx proteins have been identified through protein purification or gene cloning [1] [2] [3] [4] .
Gene-cloning experiments have described three human Gia (ai-1, -2 and -3) subunits with apparent molecular masses of 40-41 kDa, which show high similarity to each other. The inhibitory GTP-binding protein G, mediates inhibition of adenylate cyclase in numerous cell types, including platelets [5] [6] [7] [8] [9] . At least two Gia subunits (ai-2 and ai-3) are expressed in platelets [10] [11] [12] [13] . Recently, Gpa-2 has been shown to mediate a2-adrenergic inhibition of adenylate cyclase in platelets [12] and neuroblastoma cells [14] . All characterized Gca subunits are ADP-ribosylated by pertussis toxin, but only if associated with f, and y subunits [2, [15] [16] [17] . A G-protein of undefined function, G0, is also a pertussis-toxin substrate, but little or none is present in platelets [11, 12] .
Thrombin is a potent platelet activator which stimulates aggregation and secretion, inhibits adenylate cyclase and induces phospholipase C activation, arachidonate release, protein kinase C activation and Ca2+ mobilization (reviewed in [18] ). Detwiler and co-workers [19, 20] have demonstrated that chymotrypsin treatment of intact platelets modifies differentially thrombinstimulated responses. On the basis of that work, thrombin responses could be classified into two groups. Group 1 responses (adenylate cyclase inhibition and arachidonate release) are completely blocked, whereas group 2 responses (aggregation, phospholipase C and protein kinase C activation) are only slowed by chymotrypsin treatment. This led to the proposal that either two thrombin receptors are present on platelets or two distinct transducing and effector systems are coupled to one receptor. Two lines of evidence suggest that these responses are coupled to the thrombin receptor by G,-proteins. Thrombin inhibits adenylate cyclase in intact platelets and platelet membranes through a pertussis-toxin-sensitive Gi-protein [21, 22] .
Prior thrombin stimulation of intact platelets inhibits the subsequent pertussis-toxin-dependent ADP-ribosylation of membrane G, [23] . G, might also be involved in the thrombinmediated stimulation of phospholipase C [24] , but does not seem to activate the enzyme directly [25] . We describe here two distinct G, proteins which are coupled to the platelet thrombin receptor.
for 15 min. Platelets were sedimented in the presence of 250 ng of PGI2/ml by centrifugation at 2500 rev./min for 10 min. The platelet pellet was washed once in buffer A containing 1 mM-EGTA, 250 ng of PGI2/ml and apyrase (0.5 unit of ADPase/ml). Buffer A consists of 20 mM-Hepes, 138 mM-NaCl, 2.9 mM-KCl, 1 mM-MgCI2, 5 mM-glucose (pH 7.4 Chymotrypsin treatment of intact platelets Platelets were isolated as described above, but resuspended in 5 ml of buffer A (2 x 108 cells/ml). Platelet suspensions were incubated without addition or with 10 jug of chymotrypsin/ml at 25°C for 5 min with gentle shaking [19, 20] . At the end of the incubation period, 15 ml of buffer A containing 1 mM-EGTA and 250 ng of PGI2/ml was added and pellets were sedimented as described above. After two washes with buffer A supplemented with EGTA and PGI2, platelets were resuspended in 1 ml of buffer A and treated with EGTA as described above.
Platelet stimulation and ADP-ribosylation reactions Platelet suspensions were stimulated by agonists while being stirred (100 rev./min) in a LABOR-aggregometer at 37 'C. Samples (80 4a1) of platelet suspensions were removed at the times indicated in the Figure legends and added to 20,1u of an ADPribosylation cocktail, consisting of 42 mM-thymidine, 4.2 mm-ATP, 4.2 mM-EDTA, 0.5 mM-GTP, 4.2 mM-NADP+, 0.53 mg of saponin/ml, 40 jug of pertussis toxin (preactivated with 1 mmdithiothreitol at 37 'C for 30 min)/ml and lOO /tM-[32P]NAD+ (approx. 8.3 Ci/mmol). In some experiments pertussis toxin was omitted from the ADP-ribosylation cocktail. When choleratoxin-dependent ADP-ribosylation was studied, the cocktail was modified by addition of 60 mM-potassium phosphate (pH 7), 100 mM-MgCl2 and 144,tg of cholera toxin (preactivated as described above)/ml and the omission of pertussis toxin. The saponized platelet samples were incubated with ADP-ribosylation cocktail for 1 h at 37 'C with gentle shaking. After incubation, saponized platelets were fractionated by centrifugation for 5 min at room temperature at top speed in an Eppendorf 3200 microfuge. The supernatant fraction (80 ll) was immediately added to electrophoresis sample buffer (20 ,lt When immunoblotting was conducted, proteins were electrophoretically transferred from SDS/polyacrylamide gels to nitrocellulose by using the PolyBlot Transfer System (ABN, Hayward, CA, U.S.A.) and the procedure recommended by the manufacturer. Blocking of residual sites on nitrocellulose was effected by incubating blots overnight at 4°C with wash buffer [50 mM-Tris/HCI, 0.2 M-NaCl, 0.02 % NaN3, 1 mg of BSA/ml and 1 mg ofPEG (20 kDa)/ml] containing 3 % BSA. The blocked blot was incubated with a 1:2000 dilution of the Gia-specific antibody AS/6 or AS/7 in wash buffer for 1 h at room temperature. After three washes of the blot with water, antibody binding was coupled to the secondary antibody goat anti-(rabbit IgG)-alkaline phosphatase conjugate diluted 1:1000 in wash buffer, by incubation of the blot for 45 min at room temperature. After three washes of the blot, antibody binding was detected by incubating blots in 0.1 M-Tris/0. 1 M-NaCl/5 mM-MgCI2 (pH 9.5) containing 0.33 mg of NitroBlue Tetrazolium/ml and 0.17 mg of 5-bromo-4-chloro-3-indolyl phosphate/ml. Autoradiography of the immunoblot was carried out as described above. Protein bands of the dried gel or immunoblot were cut out and incorporated radioactivity was determined by liquid-scintillation counting.
For separate ADP-ribosylation of the platelet particulate and supernatant fractions, the procedure was as follows: EGTA (4 mM)-treated platelet suspensions were lysed in the presence of leupeptin (1 mM) by incubation with saponin (125 ,tg/ml) for 15 min at 37 'C. Platelet supernatant and particulate fractions were obtained by centrifugation at maximal speed in a microfuge for 5 min. Supernatant (70,l) and particulate fractions (after resuspension in 70 ,u of EGTA-containing buffer) were incubated with 20 #1 of ADP-ribosylation cocktail (see above) for 1 h at 37 'C. Samples (50 ,u1) of the supernatant were then transferred into 1 ml of ice-cold 10 % (w/v) trichloroacetic acid, and left on ice for 30 min. Samples were centrifuged at 3000 g for 15 min and the pellets were washed with 2 x 1 ml of water-saturated diethyl ether. Pellets were resuspended in 0.16 ml of sample buffer containing 1.5 % SDS and dithiothreitol. ADP-ribosylated particulate fractions were pelleted by centrifugation in a microfuge for 5 min and resuspended in 0.1 ml of sample buffer. Proteins were separated on SDS/PAGE (10 %) gels (20 cm long, 1.5 mm thick). The gels were dried and exposed to Kodak X-OMAT-AR2 or BB5 films at 80 'C by using cassettes with an intensifying screen.
Immunoprecipitation of Gia from platelets
This was done by the methods described in ref. [30] . The following antisera [9, 26, 27] were used: an anti-G1a common antiserum (AS/7), which was produced against the C-terminal decapeptide (KENLKDCGLF) of rod transducin; the antiserum anti-Goa (GO/1), which was produced against an internal sequence of brain G,a; and the antiserum anti-Gia-1 (LD/2), whichwasproducedagainstaninternalsequence(LDRIAQPNYI) of Gia-1. SDS, aprotinin (20 ,ug/ml), NaCl (150 mM), Na2HPO4 (50 mM) and dithiothreitol (2 mM), and heated for 1 min at 90 'C. Then 80,ul of 10 x RIPA (10% deoxycholate, 10% Triton X-100, 150 mM-NaCl and 50 mM-Na2HPO4) was added to clear the extract. Samples (0.4 ml) were incubated with 4 u1 of normal rabbit serum for 1 h at 4 'C. Then Protein A-Sepharose (see above) coated with BSA (5 mg in 100 ,ul of RIPA containing 1 % deoxycholate and 1 % Triton X-100) was added and incubated for 1 h on ice. After centrifugation in a microfuge for 5 min, the supernatant (0.45 ml) was incubated with 4 #1 of specific antiserum for 1 h at 4 'C, and then with 100 41 of Protein A-Sepharose for 1 h at 4 'C. After centrifugation, the supernatant was discarded and Protein A-Sepharose was washed with 3 x 1 ml of RIPA buffer and once with phosphate-buffered saline. The samples were resuspended in 100 ,ul ofelectrophoresis sample buffer and treated for 3 min at 100 'C. The supernatant was separated by SDS/PAGE (10% gels).
ribosylated in a pertussis-toxin-dependent manner (Fig. 3) . The ADP-ribosylation by pertussis toxin of this soluble protein was completely inhibited in thrombin-stimulated platelets (Fig. 3) . Thrombin is the only agonist which rapidly and significantly inhibited the pertussis-toxin-dependent ADP-ribosylation of both membrane G1a (60 % inhibition after 5 
RESULTS
Immunoblot analysis of Gia from thrombin-stimulated platelets
The inability of pertussis toxin to ADP-ribosylate Gi after thrombin stimulation is believed to be due to a receptor-mediated G-protein dissociation [23] , since the isolated Gia subunit is not a good pertussis-toxin substrate [2, [15] [16] [17] . It has been suggested that the a,-subunit dissociated from fly may be released to the cell cytoplasm [31] . If Gpa protein (80 % inhibition after 5 s) (Fig. 4) (Fig. 4) . The ADP-ribosylated soluble protein had a slightly higher electrophoretic mobility than the ADP-ribosylated membrane Gia (Fig. 5) , indicating an apparent molecular mass (40 kDa) slightly lower than the main Gpa protein in platelet membranes (Gia-2; 41 kDa). The presence of excess unlabelled NADI inhibited labelling of the soluble protein with [32P]NAD+ (Fig. 3) , and labelling could be achieved with [adenosine-14C]NAD+ (Fig.  5) ribosylation of the soluble Gia protein was not observed (Fig. 6) .
Interestingly, in these experiments a further soluble ADPribosylated protein with higher molecular mass was observed ('X') that was responsive to thrombin. The decrease of ADPribosylation of that protein after pretreatment of platelets with thrombin was blocked by prior addition of leupeptin (Fig. 6) . The 41 kDa protein in platelet membranes (G.a) could be ADPribosylated by pertussis toxin in the absence of cytosol (results not shown). Thrombin pretreatment of intact platelets decreased the subsequent ADP-ribosylation of the membrane 41 kDa protein, an effect that was prevented again by the prior addition of leupeptin (results not shown).
Immunoprecipitation studies were performed to characterize further the soluble G1cc protein. A specific antiserum against G1a subunits immunoprecipitated the soluble 40 kDa ADPribosylated protein (Fig. 7) . It also precipitated the membrane 41 kDa ADP-ribosylated protein, as observed previously [11, 29] . Both proteins showed a decrease in pertussis-toxin-dependent ADP-ribosylation after pretreatment of platelets with thrombin. The 37 'C. Then the samples were centrifuged in a microfuge for 5 min to obtain the supernatant. At the end of the ADP-ribosylation, portions (50,u) of all samples were transferred into 10 % trichloroacetic acid as described in the Experimental section. soluble or membrane ADP-ribosylated proteins (Fig. 7) . These results indicate that the soluble 40 kDa protein belongs to the Gia protein family, but is most likely not Gca-l.
Thrombin inhibits -the pertussis-toxin-dependent ADP-ribosylation of the soluble Gjox protein
It was possible to demonstrate functional differences in the soluble 40 kDa and the membrane 41 kDa Gia proteins. The proteinase inhibitor leupeptin is capable of preventing thrombinstimulated platelet activation [33, 34] . We observed that leupeptin inhibited thrombin-induced platelet aggregation (results not shown) and in parallel prevented thrombin-induced inhibition of membrane G1a ADP-ribosylation (Fig. 8) . In contrast, leupeptin did not affect the thrombin-induced inhibition of ADPribosylation of the soluble 40 kDa protein (Fig. 8) . Furthermore, mild chymotrypsin pretreatment of platelets [19, 20] was found to abolish completely the inhibition by thrombin of membrane Gia ADP-ribosylation. In contrast, chymotrypsin digestion inhibited by only 30% the thrombininduced decrease in ADP-ribosylation of the soluble protein Vol. 279 -CHY + CHY Fig. 9 . Thrombin inhibits pertussis-toxin-dependent ADP-ribosylation of the soluble Gsa, but not the membrane G1a in chymotrypsin-treated platelets Intact platelets were incubated without (-CHY) or with chymotrypsin (+CHY) as described in the Experimental section. Samples of platelet suspensions were removed before (C) and 5 and 15 s after thrombin (TH) addition (1 unit/ml) and were added to portions of an ADP-ribosylation cocktail containing pertussis toxin. Supernatant (S) and pellet (P) proteins were separated by SDS/PAGE. An Samples of platelet suspensions were removed 5 s after addition of thrombin at the indicated concentrations and were added to portions of an ADP-ribosylation cocktail containing pertussis toxin. Supernatant (S) and pellet (P) proteins were separated by SDS/PAGE, and the radioactivity in gel slices containing membrane Gia (0) and the soluble Gia protein (0) was determined.
proteins are individually coupled to different receptors with a similar affinity for thrombin.
DISCUSSION
The observation that thrombin stimulation can inhibit the subsequent pertussis-toxin-dependent ADP-ribosylation of Giac is believed to indicate that receptor activation results in the dissociation of the a-subunit from fly of Gi [23, 24] . This subunit dissociation could also be accompanied by a movement of Gia from plasma membrane to the cytosol [31] . We have been unable to observe any agonist-stimulated decrease in immunodetectable Gia associated with platelet membranes which would quantitatively correspond to the 70 % inhibition of ADP-ribosylation caused by thrombin. Our immunoblot analysis would have been able to detect cytosolic G1a if the quantity released from the membrane was proportional to ADP-ribosylation. Our data do not eliminate the possibility that minor amounts of G1a are solubilized in response to thrombin stimulation. Therefore our results suggest that G1a, although dissociated from f and y subunits, is not released from the plasma membrane of activated platelets. Instead, we detected a soluble protein, ADP-ribosylated in a pertussis-toxin-dependent manner, that responds specifically to thrombin stimulation of platelets. This protein is slightly smaller than membrane G1a in molecular mass. It is present in platelets at only 5 % the level of Gia, assuming both proteins are ADP-ribosylated to equivalent extents. Owing to the small amounts of soluble Gia proteins, we have been unable to detect on immunoblots any soluble proteins which react with anti-G1a antisera. However, the ADP-ribosylated soluble 40 kDa protein could be immunoprecipitated with antisera against G1ac but not against G1a-l. It has been demonstrated that the pertussis-toxin substrates in platelet membranes are G1a-2 and G1a-3 (apparent molecular mass 40-41 kDa), with G1a-2 being much more abundant than Gia-3 [10] [11] [12] [13] . Gia-l is absent from [12] , or only present in minute amounts [13] in, platelets, whereas Goa could not be detected [11] [12] [13] , results that were partly confirmed by our study.
Gia proteins are tethered to the plasma membrane via their Nterminal end [35] . Myristoylation of glycine in position 2 of G1a is essential for its membrane attachment [36] [37] [38] . The soluble G1a protein found in our study in platelets might not be myristoylated; it could be lacking the N-terminal glycine carrying the myristoylation site or be a clipped product of the major ADPribosylated membrane Gia. This also could explain its faster mobility on SDS/PAGE. As the C-terminus is the site of ADPribosylation, and G-protein ADP-ribosylation requires an interaction of the N-terminus of the a-subunit with the ,-subunit, the (Fig. 9 ). (Fig. 10 ). This suggests that both proteins are coupled to the same thrombin receptor, although the possibility cannot be eliminated that both cytosolic G-protein must retain considerable essential structure. In effect, the presence of this soluble G-protein in resting platelets and retention of coupling to the thrombin receptor are evidence of a distinct biological function.
Although a membrane and a soluble G1a protein appear to be coupled to the thrombin receptor, they can be functionally differentiated. Leupeptin or chymotrypsin treatment of platelets prevented the thrombin-stimulated inhibition of membrane G1a ADP-ribosylation, but did not block the inhibition of ADPribosylation of the soluble protein. Characteristics of the two proteins are summarized in Table 1 . Although the structural relationship of the two proteins remains to be clearly established, the differences between the membrane and the soluble G a protein suggest that the latter is the a, subunit of a G-protein which is functionally distinct from membrane Gia. Since ADPribosylation of the soluble G1a protein was only observed in the presence of platelet membranes, we conclude that the soluble G1a protein was ADP-ribosylated by pertussis toxin while bound to putative ,-and y-subunits attached to the plasma membrane. This ADP-ribosylated subunit could then dissociate from the membrane to account for the observed supernatant subcellular location in saponized platelets. Occupancy of the thrombin receptor could lead to a conformational or covalent change of the soluble G1a and hence to its lack ofinteraction with membrane fly-subunits that is required for ADP-ribosylation by pertussis toxin.
Minor amounts ofa pertussis-toxin-sensitive soluble G-protein having the same molecular mass as the main pertussis-toxin substrates (40 kDa) in membranes have been previously observed in bovine and human neutrophils [39] [40] [41] . The quantity of cytosolic pertussis-toxin-sensitive az-2 in renal epithelial cells remained unaltered, whereas the amount of membraneassociated protein increased upon cell stimulation [42] . The functional and biological relevance of these soluble proteins remains unclear. Mutations which prevent myristoylation of ac expressed in COS cells interfered with membrane association [37, 38] , but did not prevent pertussis-toxin-dependent ADPribosylation [38] . This indicates that soluble a-subunits are still capable of interaction with fly-subunits and is consistent with the present identification of a functional soluble G-protein in platelets. A soluble pertussis-toxin substrate having the same molecular mass as membrane G1a (41 kDa) has previously been described in platelets [43] . It was speculated that this soluble Gprotein may be responsible for the GTP-dependent activation of purified soluble phospholipase C. This fits well with our speculation that the soluble G-protein may be a regulatory protein which couples the thrombin receptor to a chymotrypsininsensitive response (see the discussion below). Another cytosolic platelet G-protein has been observed [44] , but, on the basis of its different size and toxin-sensitivity, is distinct from the protein described here.
The platelet thrombin receptor(s) has not yet been identified. Thrombin has hormone-like and enzyme-like properties, and it interacts with the platelet surface at several specific sites (for references see [18] ). The proteinase inhibitor leupeptin prevents thrombin-catalysed proteolysis and platelet activation, without inhibiting thrombin binding [45] . Though the exact mode of action is not known, mild chymotrypsin treatment of intact platelets apparently cleaves a thrombin-sensitive ligand, thereby inhibiting certain thrombin-stimulated responses [19, 20] . The results of our experiments with leupeptin and chymotrypsin treatment of platelets indicate that thrombin-receptor occupancy alone is sufficient to trigger the inhibition of the pertussis-toxindependent ADP-ribosylation of the soluble G1 protein. Activation of that G1 protein might be an initial event after binding of thrombin to its receptor, but alone it is insufficient to stimulate platelet activation. In contrast, both receptor occupancy and thrombin-induced proteolysis are required for the inhibition of membrane Gia ADP-ribosylation. This interpretation fits well the findings of Detwiler and co-workers [19] . They found that chymotrypsin treatment of intact platelets blocked thrombinstimulated responses (adenylate cyclase regulation and arachidonate release) which are recognized as being coupled to G1, whereas responses such as activation of phospholipase C and protein kinase C (chymotrypsin-insensitive responses), which are coupled to as yet undefined regulatory proteins, were only decreased. To explain these findings, the proposal was made that either two thrombin receptors or one receptor coupled to two variant signal-transducing mechanisms are present in platelets. Under similar conditions (chymotrypsin or leupeptin treatment)
we observe a selective inhibition of membrane Gi activation with retention of thrombin-stimulated soluble G, protein activation.
This suggests that two distinct platelet G-proteins are activated by thrombin. The similarity in the dose-response curves for thrombin activation of these two G-proteins favours the hypothesis that both effectors are coupled to one thrombin receptor. It will be important to determine whether the thrombin-coupled 'soluble' G a protein described here is a regulatory protein coupled to any of the chymotrypsin-insensitive responses described by Detwiler [19, 20] .
